Unichem Laboratories Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹575.12 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.35 per cent from ₹521.17 crore. This corresponds to a year-on-year *(YoY) decline of 2.05 per cent.
Operating Profit
Operating Profit stands at ₹35.32 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 21.13 per cent from ₹44.78 crore. This corresponds to a year-on-year *(YoY) decline of 57.80 per cent.
PBDT
PBDT stands at ₹49.40 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 84.79 per cent from ₹324.68 crore. This corresponds to a year-on-year *(YoY) decline of 43.54 per cent.
Profit Before Tax
Profit Before Tax stands at ₹18.79 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 93.60 per cent from ₹293.43 crore. This corresponds to a year-on-year *(YoY) decline of 67.49 per cent.
Net Profit
Net Profit stands at ₹10.91 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 95.87 per cent from ₹264.29 crore. This represents a 79.40 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Unichem Laboratories Ltd News
Unichem Laboratories Ltd Earnings
- YOY
- QOQ
Unichem Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Unichem Laboratories Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Unichem Laboratories Ltd Financial Reports
Unichem Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Unichem Labs. | 3.30% | 1.15% | 34.20% | 45.31% | 12.95% | -20.00% |
| Novartis India | -0.34% | 0.48% | 7.36% | 45.16% | 81.63% | 39.83% |
| Advanced Enzyme | -1.41% | 1.19% | -15.28% | 8.78% | 5.60% | -3.69% |
| Aarti Drugs | 2.45% | 3.49% | 6.22% | 7.50% | -1.04% | -18.26% |
| Morepen Labs. | 0.36% | -2.57% | 42.49% | 51.85% | 50.36% | -3.86% |
| Panacea Biotec | -0.13% | -1.44% | -3.12% | 61.64% | 24.17% | 32.82% |
| Dishman Carbogen | 0.43% | 12.09% | 6.98% | 21.50% | -23.97% | -23.53% |
Company Info
Company Information
Non-Executive & Non-Independent Director : Pranay Godha
Managing Director & Chief Executive Officer : Pabitra Bhattacharya
Company Sec. & Compli. Officer : Pradeep Bhandari
Chairman (Non-Executive) : Prakash A Mody
Independent Director : Anand T Kusre
Independent Director : Arun Todarwal
Independent Director : Swati Patankar